Does the media favor IART or MMED?

In the previous week, Integra LifeSciences had 1 more articles in the media than MiniMed Group. MarketBeat recorded 2 mentions for Integra LifeSciences and 1 mentions for MiniMed Group. Integra LifeSciences' average media sentiment score of 1.22 beat MiniMed Group's score of 0.00 indicating that Integra LifeSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer HAE or IART?

In the previous week, Haemonetics had 20 more articles in the media than Integra LifeSciences. MarketBeat recorded 22 mentions for Haemonetics and 2 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.22 beat Haemonetics' score of 0.96 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 13 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Integra LifeSciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to LIVN or IART?

In the previous week, LivaNova had 2 more articles in the media than Integra LifeSciences. MarketBeat recorded 4 mentions for LivaNova and 2 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.22 beat LivaNova's score of 0.14 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Integra LifeSciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ITGR or IART?

In the previous week, Integer had 6 more articles in the media than Integra LifeSciences. MarketBeat recorded 8 mentions for Integer and 2 mentions for Integra LifeSciences. Integer's average media sentiment score of 1.42 beat Integra LifeSciences' score of 1.22 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IART or IRTC?

In the previous week, iRhythm Technologies had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 6 mentions for iRhythm Technologies and 2 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.22 beat iRhythm Technologies' score of 0.28 indicating that Integra LifeSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Integra LifeSciences (IART) Competitors

$16.74 +0.15 (+0.90%)

As of 08/21/2026 04:00 PM Eastern

Compare

IART vs. MMED, HAE, LIVN, ITGR, and IRTC

Should you buy Integra LifeSciences stock or one of its competitors? Integra LifeSciences's main competitors and comparable companies include MiniMed Group (MMED), Haemonetics (HAE), LivaNova (LIVN), Integer (ITGR), and iRhythm Technologies (IRTC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Integra LifeSciences compare to MiniMed Group?

Integra LifeSciences (NASDAQ:IART) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations.

84.8% of Integra LifeSciences shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Integra LifeSciences had 1 more articles in the media than MiniMed Group. MarketBeat recorded 2 mentions for Integra LifeSciences and 1 mentions for MiniMed Group. Integra LifeSciences' average media sentiment score of 1.22 beat MiniMed Group's score of 0.00 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integra LifeSciences currently has a consensus target price of $18.86, suggesting a potential upside of 12.65%. MiniMed Group has a consensus target price of $21.62, suggesting a potential upside of 5.70%. Given Integra LifeSciences' higher probable upside, equities analysts clearly believe Integra LifeSciences is more favorable than MiniMed Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

MiniMed Group has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than MiniMed Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.80	-$516.47M	-$0.09	N/A
MiniMed Group	$3.10B	1.85	-$333M	-$0.68	N/A

MiniMed Group has a net margin of 0.00% compared to Integra LifeSciences' net margin of -0.44%. Integra LifeSciences' return on equity of 18.30% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-0.44%	18.30%	5.30%
MiniMed Group	N/A	N/A	N/A

Summary

Integra LifeSciences beats MiniMed Group on 8 of the 14 factors compared between the two stocks.

How does Integra LifeSciences compare to Haemonetics?

Haemonetics (NYSE:HAE) and Integra LifeSciences (NASDAQ:IART) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

99.7% of Haemonetics shares are owned by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are owned by institutional investors. 2.1% of Haemonetics shares are owned by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Haemonetics has a net margin of 7.12% compared to Integra LifeSciences' net margin of -0.44%. Haemonetics' return on equity of 27.55% beat Integra LifeSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.12%	27.55%	9.65%
Integra LifeSciences	-0.44%	18.30%	5.30%

Haemonetics has higher earnings, but lower revenue than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.33B	3.71	$97.31M	$2.04	53.38
Integra LifeSciences	$1.64B	0.80	-$516.47M	-$0.09	N/A

In the previous week, Haemonetics had 20 more articles in the media than Integra LifeSciences. MarketBeat recorded 22 mentions for Haemonetics and 2 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.22 beat Haemonetics' score of 0.96 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	13 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Integra LifeSciences	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Haemonetics currently has a consensus price target of $97.56, indicating a potential downside of 10.41%. Integra LifeSciences has a consensus price target of $18.86, indicating a potential upside of 12.65%. Given Integra LifeSciences' higher probable upside, analysts clearly believe Integra LifeSciences is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

Haemonetics has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.21, meaning that its share price is 21% more volatile than the broader market.

Summary

Haemonetics beats Integra LifeSciences on 12 of the 17 factors compared between the two stocks.

How does Integra LifeSciences compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Integra LifeSciences (NASDAQ:IART) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

In the previous week, LivaNova had 2 more articles in the media than Integra LifeSciences. MarketBeat recorded 4 mentions for LivaNova and 2 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.22 beat LivaNova's score of 0.14 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integra LifeSciences	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LivaNova has a net margin of 12.82% compared to Integra LifeSciences' net margin of -0.44%. Integra LifeSciences' return on equity of 18.30% beat LivaNova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	12.82%	16.35%	7.76%
Integra LifeSciences	-0.44%	18.30%	5.30%

LivaNova presently has a consensus target price of $83.50, indicating a potential upside of 6.05%. Integra LifeSciences has a consensus target price of $18.86, indicating a potential upside of 12.65%. Given Integra LifeSciences' higher possible upside, analysts clearly believe Integra LifeSciences is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

97.6% of LivaNova shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 0.4% of LivaNova shares are held by insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

LivaNova has higher earnings, but lower revenue than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	3.12	-$242.47M	$3.38	23.30
Integra LifeSciences	$1.64B	0.80	-$516.47M	-$0.09	N/A

LivaNova has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market.

Summary

LivaNova beats Integra LifeSciences on 10 of the 16 factors compared between the two stocks.

How does Integra LifeSciences compare to Integer?

Integer (NYSE:ITGR) and Integra LifeSciences (NASDAQ:IART) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

Integer has a net margin of 6.97% compared to Integra LifeSciences' net margin of -0.44%. Integra LifeSciences' return on equity of 18.30% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Integra LifeSciences	-0.44%	18.30%	5.30%

In the previous week, Integer had 6 more articles in the media than Integra LifeSciences. MarketBeat recorded 8 mentions for Integer and 2 mentions for Integra LifeSciences. Integer's average media sentiment score of 1.42 beat Integra LifeSciences' score of 1.22 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market.

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.30	$102.81M	$3.66	34.21
Integra LifeSciences	$1.64B	0.80	-$516.47M	-$0.09	N/A

99.3% of Integer shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Integer currently has a consensus price target of $109.86, indicating a potential downside of 12.27%. Integra LifeSciences has a consensus price target of $18.86, indicating a potential upside of 12.65%. Given Integra LifeSciences' higher possible upside, analysts plainly believe Integra LifeSciences is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88

Summary

Integer beats Integra LifeSciences on 11 of the 15 factors compared between the two stocks.

How does Integra LifeSciences compare to iRhythm Technologies?

Integra LifeSciences (NASDAQ:IART) and iRhythm Technologies (NASDAQ:IRTC) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings, media sentiment and dividends.

Integra LifeSciences presently has a consensus price target of $18.86, indicating a potential upside of 12.65%. iRhythm Technologies has a consensus price target of $179.93, indicating a potential upside of 40.00%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.88
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

Integra LifeSciences has a net margin of -0.44% compared to iRhythm Technologies' net margin of -1.69%. Integra LifeSciences' return on equity of 18.30% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-0.44%	18.30%	5.30%
iRhythm Technologies	-1.69%	10.11%	1.53%

84.8% of Integra LifeSciences shares are held by institutional investors. 3.8% of Integra LifeSciences shares are held by company insiders. Comparatively, 1.0% of iRhythm Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

iRhythm Technologies has lower revenue, but higher earnings than Integra LifeSciences. iRhythm Technologies is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.80	-$516.47M	-$0.09	N/A
iRhythm Technologies	$747.14M	5.67	-$44.55M	-$0.43	N/A

Integra LifeSciences has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market.

In the previous week, iRhythm Technologies had 4 more articles in the media than Integra LifeSciences. MarketBeat recorded 6 mentions for iRhythm Technologies and 2 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 1.22 beat iRhythm Technologies' score of 0.28 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Integra LifeSciences beats iRhythm Technologies on 9 of the 17 factors compared between the two stocks.

Get Integra LifeSciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IART vs. The Competition

Export

Metric	Integra LifeSciences	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.30B	$6.02B	$7.37B	$12.83B
Dividend Yield	N/A	1.74%	2.53%	10.78%
P/E Ratio	-185.98	21.93	211.58	20.91
Price / Sales	0.80	71.62	625.25	96.27
Price / Cash	3.97	33.71	29.03	36.90
Price / Book	1.25	6.22	11.25	6.42
Net Income	-$516.47M	$149.90M	$3.47B	$348.89M
7 Day Performance	-8.72%	0.69%	2.09%	0.08%
1 Month Performance	-9.81%	8.91%	6.64%	3.88%
1 Year Performance	12.65%	8.07%	25.02%	16.98%

Integra LifeSciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IART Integra LifeSciences	1.8162 of 5 stars	$16.74 +0.9%	$18.86 +12.6%	+12.7%	$1.30B	$1.64B	N/A	4,427	Positive News
MMED MiniMed Group	1.6689 of 5 stars	$19.82 +1.5%	$21.62 +9.1%	N/A	$5.57B	$3.10B	N/A	2,800
HAE Haemonetics	2.1004 of 5 stars	$105.56 +16.9%	$92.44 -12.4%	+93.5%	$4.80B	$1.33B	51.73	3,009	News Coverage Analyst Forecast
LIVN LivaNova	2.4762 of 5 stars	$79.98 -1.8%	$83.50 +4.4%	+40.9%	$4.41B	$1.47B	23.68	3,300	Positive News Analyst Upgrade
ITGR Integer	2.6607 of 5 stars	$125.22 +0.1%	$109.86 -12.3%	+13.2%	$4.26B	$1.85B	34.21	11,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IART) was last updated on 8/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integra LifeSciences (IART) Competitors

IART vs. MMED, HAE, LIVN, ITGR, and IRTC

How does Integra LifeSciences compare to MiniMed Group?

Summary

How does Integra LifeSciences compare to Haemonetics?

Summary

How does Integra LifeSciences compare to LivaNova?

Summary

How does Integra LifeSciences compare to Integer?

Summary

How does Integra LifeSciences compare to iRhythm Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IART vs. The Competition

Integra LifeSciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integra LifeSciences (IART) Competitors

IART vs. MMED, HAE, LIVN, ITGR, and IRTC

How does Integra LifeSciences compare to MiniMed Group?

Do insiders and institutionals have more ownership in IART or MMED?

Does the media favor IART or MMED?

Do analysts recommend IART or MMED?

Which has higher earnings and valuation, IART or MMED?

Is IART or MMED more profitable?

Summary

How does Integra LifeSciences compare to Haemonetics?

Do insiders & institutionals believe in HAE or IART?

Is HAE or IART more profitable?

Which has higher valuation & earnings, HAE or IART?

Does the media prefer HAE or IART?

Do analysts rate HAE or IART?

Which has more volatility & risk, HAE or IART?

Summary

How does Integra LifeSciences compare to LivaNova?

Does the media refer more to LIVN or IART?

Is LIVN or IART more profitable?

Do analysts prefer LIVN or IART?

Do institutionals and insiders believe in LIVN or IART?

Which has higher earnings & valuation, LIVN or IART?

Which has more volatility & risk, LIVN or IART?

Summary

How does Integra LifeSciences compare to Integer?

Is ITGR or IART more profitable?

Does the media prefer ITGR or IART?

Which has more risk and volatility, ITGR or IART?

Which has stronger valuation & earnings, ITGR or IART?

Do institutionals & insiders believe in ITGR or IART?

Do analysts prefer ITGR or IART?

Summary

How does Integra LifeSciences compare to iRhythm Technologies?

Do analysts recommend IART or IRTC?

Is IART or IRTC more profitable?

Do institutionals and insiders hold more shares of IART or IRTC?

Which has higher valuation and earnings, IART or IRTC?

Which has more risk and volatility, IART or IRTC?

Does the media favor IART or IRTC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IART vs. The Competition

Integra LifeSciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools